The presence of lupus anticoagulant, moderate-to-high levels of IgG and/or IgM antibodies
to beta-2 glycoprotein I or cardiolipin in association with at least one of the two major clinical …

Current classification criteria for definite antiphospholipid syndrome (APS) mandate the use
of one or more of three positive 'standardized'laboratory assays to detect antiphospholipid …

Antiphospholipid antibodies are autoantibodies directed against anionic phospholipids or
protein-phospholipid complexes measured in solid-phase immunoassays such as …

Antiphospholipid antibodies (aPLs) are a heterogeneous group of antibodies directed
against phospholipids or protein/phospholipid complexes. Currently, aPLs are assessed …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by thrombosis
and/or pregnancy-related morbidity accompanied by persistently positive antiphospholipid …

The antiphospholipid syndrome (APS) is an autoimmune condition characterized by
vascular thromboses and/or pregnancy morbidity, and its diagnosis currently requires …

Background: The antiphospholipid syndrome (APS) is an important cause of acquired
thromboembolic complications and pregnancy morbidity. Its diagnosis is based on clinical …

Antiphospholipid syndrome (APS) is a hypercoagulation condition associated with the
incidence of heterogenic antiphospholipid antibodies (aPLs), which non-specifically affect …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by recurrent
vascular thrombosis (VT) and/or pregnancy morbidity (PM) in the presence of persistent …

The diagnosis of seronegative antiphospholipid syndrome (APS) has been proposed for
patients with well-defined clinical APS but persistently negative for the routinely tested …